EUVIMEDEUVIMED entdecken
Fallbericht

Gaucher Disease Treated With Lentiviral‐Mediated Gene Therapy: First Case

Mona Shafey, Nicole Prokopishyn, Aneal Khan iD

Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)

DOI: 10.1002/jimd.70221 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 21.06.2026. Verfasst von Mona Shafey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology & Hematologic Malignancies, Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Gaucher Disease, Genetic Therapy, Lentivirus, Glucosylceramidase. Die Arbeit nennt 8 Literaturangaben. Gefördert von: AVROBIO, M.A.G.I.C. Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gaucher disease is a rare, autosomal recessive disease, with decreased activity of lysosomal glucocerebrosidase (GCase) due to changes in the GBA1 gene. There is no cure for Gaucher disease, and standard treatment involves the use of enzyme replacement therapy or substrate reduction therapy. We describe the first case of Gaucher disease that was treated with an autologous transplant of lentivirus‐transduced CD34 + cells. Enzyme therapy was stopped 4 weeks prior to Day 0 of transplant. At 5 years of follow‐up, dried blood spot GCase enzyme levels have remained in the normal range; there has been a consistent and sustained reduction of lyso‐GB1 and liver volume, and hematological indices such as leukocyte count, hemoglobin, and platelet count have remained in the normal range despite no additional therapy for the Gaucher disease. This case shows a sustained response to a single dose of lentiviral gene therapy for Gaucher disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gaucher DiseaseGenetic TherapyLentivirusGlucosylceramidaseHumansGene Therapy AgentsGenetic VectorsTreatment OutcomeMale

Stichwörter der Autor:innen

Gaucher diseaselentiviral gene therapylysosomal disease

Substanzen

Glucosylceramidase

Autor:innen und Institutionen

  • Division of Hematology & Hematologic Malignancies, Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Department of Diagnostics and Laboratory Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • M.A.G.I.C. Clinic (Metabolics and Genetics in Canada), Calgary, Alberta, Canada.

ORCID-Profile: Aneal Khan

Förderung

  • AVROBIO
  • M.A.G.I.C. Clinic

Zitieren

APA

Shafey, M., Prokopishyn, N., & Khan, A. (2026). Gaucher Disease Treated With Lentiviral‐Mediated Gene Therapy: First Case. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70221

Vancouver

Shafey M, Prokopishyn N, Khan A. Gaucher Disease Treated With Lentiviral‐Mediated Gene Therapy: First Case. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70221

BibTeX
@article{Shafey2026,
  author = {Shafey, Mona and Prokopishyn, Nicole and Khan, Aneal},
  title = {Gaucher Disease Treated With Lentiviral‐Mediated Gene Therapy: First Case},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/jimd.70221}
}
Kostenlos starten →